Literature DB >> 9203374

Differential cytotoxic effects induced after photosensitization by hypericin.

A L Vandenbogaerde1, J F Cuveele, P Proot, B E Himpens, W J Merlevede, P A de Witte.   

Abstract

The cytotoxic effects of the natural photosensitizing agent hypericin were evaluated. A dramatic difference in the sensitivity of several different human and mouse cell lines towards photoactivated hypericin (4 J cm-2) was demonstrated using a neutral red assay (e.g. A431, IC50 = 0.14 +/- 0.02 microM; HeLa, IC50 = 0.32 +/- 0.05 microM, MCF7, IC50 = 1.84 +/- 0.22 microM). Dark cytotoxicity was absent, even at high hypericin concentration (25 microM). The differential phototoxicity of hypericin did not correlate with the expression of the epidermal growth factor (EGF) receptor nor with the expression of the P170 glycoprotein in the cell. The reduction of the intracellular glutathione content did not enhance further the cytotoxic effects of photoactivated hypericin, as investigated with the A431, HeLa and MCF7 cells. Conversely, using confocal laser microscopy, it was shown that the phototoxicity correlated well with the hypericin cellular uptake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203374     DOI: 10.1016/s1011-1344(96)07446-5

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  12 in total

1.  Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells.

Authors:  Maha Fadel; Kawser Kassab; Tareq Youssef
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

2.  Topically applied hypericin exhibits skin penetrability on nude mice.

Authors:  Zhuo-Heng Li; Yuan-Yuan Li; Min Hou; Tao Yang; Lai-Chun Lu; Xiao-Yu Xu
Journal:  Lasers Med Sci       Date:  2018-06-13       Impact factor: 3.161

Review 3.  Exploring the anticancer activities of novel bioactive compounds derived from endophytic fungi: mechanisms of action, current challenges and future perspectives.

Authors:  Rubina Kousar; Muhammad Naeem; Mohamad Ikhwan Jamaludin; Ammara Arshad; Aisyah Nazirah Shamsuri; Nelofar Ansari; Samreen Akhtar; Abu Hazafa; Jalal Uddin; Ajmal Khan; Ahmed Al-Harrasi
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

4.  Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model.

Authors:  K E Wright; E Liniker; M Loizidou; C Moore; A J Macrobert; J B Phillips
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

5.  Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.

Authors:  Junjie Li; Raymond Oyen; Alfons Verbruggen; Yicheng Ni
Journal:  J Cancer       Date:  2013-01-22       Impact factor: 4.207

6.  Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.

Authors:  Jingwen Yi; Xiaoguang Yang; Lihua Zheng; Guang Yang; Luguo Sun; Yongli Bao; Yin Wu; Yanxin Huang; Chunlei Yu; Shao-Nian Yang; Yuxin Li
Journal:  Biosci Rep       Date:  2015-04-20       Impact factor: 3.840

7.  Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane.

Authors:  Martin Majerník; Rastislav Jendželovský; Marián Babinčák; Ján Košuth; Juraj Ševc; Zuzana Tonelli Gombalová; Zuzana Jendželovská; Monika Buríková; Peter Fedoročko
Journal:  Int J Mol Sci       Date:  2019-06-19       Impact factor: 5.923

8.  In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.

Authors:  Rainer Ritz; Christian Scheidle; Susan Noell; Florian Roser; Martin Schenk; Klaus Dietz; Wolfgang S L Strauss
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy.

Authors:  Ramaswamy Bhuvaneswari; Yik Y Gan; Sasidharan S Lucky; William W L Chin; Seyed M Ali; Khee C Soo; Malini Olivo
Journal:  Mol Cancer       Date:  2008-06-13       Impact factor: 27.401

Review 10.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.